AgenusAGEN
Market Cap: $107M
About: Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
Employees: 389
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
1,235% more call options, than puts
Call options by funds: $42.6M | Put options by funds: $3.19M
420% more capital invested
Capital invested by funds: $157M [Q1] → $815M (+$659M) [Q2]
7.92% less ownership
Funds ownership: 49.59% [Q1] → 41.67% (-7.92%) [Q2]
30% less funds holding
Funds holding: 125 [Q1] → 88 (-37) [Q2]
57% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 65
97% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 58
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
B. Riley Securities Yuan Zhi 40% 1-year accuracy 4 / 10 met price target | 264%upside $18 | Buy Maintained | 14 Aug 2024 |
Jefferies Biren Amin 57% 1-year accuracy 8 / 14 met price target | 39%downside $3 | Hold Downgraded | 19 Jul 2024 |
HC Wainwright & Co. Emily Bodnar 28% 1-year accuracy 30 / 108 met price target | 82%upside $9 | Neutral Downgraded | 18 Jul 2024 |
HC Wainwright & Co. Emily Bodnar 28% 1-year accuracy 30 / 108 met price target | 708%upside $40 | Buy Reiterated | 28 Jun 2024 |
Financial journalist opinion
Based on 37 articles about AGEN published over the past 30 days